abstract |
FIELD OF THE INVENTION The present invention generally relates to the field of treatment of ligands for nicotinic acetylcholine receptor (nAChR), activation of nAChR, and disease symptoms associated with nicotinic acetylcholine receptors, particularly of defective or dysfunctional brains. The present invention further relates to novel compounds (indazoles and benzothiazoles) which serve as ligands of the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds and methods of use thereof. |